Publication | Closed Access
663P Safety and preliminary efficacy of the KRAS G12C Inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC
14
Citations
0
References
2023
Year
OncologySolid TumorsMedicineImmune Checkpoint InhibitorPharmacotherapyPreliminary EfficacyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyNovel Therapy
No additional data available for this publication yet. Check back later!